Trial intelligence / Profile preview

Deep vs Moderate NMB in Laparoscopic Surgery

NCT02025075Completed

Sponsor
Massachusetts General Hospital
Start
Jan 2014
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of rocuronium, sponsored by Massachusetts General Hospital. Primary endpoint: Regional Change in Air Content (Delta Z). Started Jan 2014; status: completed.

02

Drugs

rocuronium

Beyond the preview

Go deeper on NCT02025075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02025075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call